Company: XAIR
Filing Date: 2025-06-20
Form Type: 10-K
Source: 0001641172-25-015750
Chunk: 798

Company: Beyond Air, Inc.
Filing Date: 2025-06-20
Form: 10-K
Item: Item 1A
Chunk 798
---
 addition to being forced to pay damages, we may be temporarily or permanently
prohibited from commercializing our approved product or product candidate that is held to be infringing. We might, if possible, also
be forced to redesign our approved product or product candidate so that we no longer infringe the third-party intellectual property rights.
Any of these events, even if we were ultimately to prevail, could require us to divert substantial financial and management resources
that we would otherwise be able to devote to our business.

Patent terms are limited and we may not be able
to effectively protect our products and business.

Patents have a limited lifespan.
In the U.S., the natural expiration of a patent is generally 20 years after it is filed. Although various extensions may be available,
the life of a patent, and the protection it affords, is limited.

In addition, upon issuance in
the U.S., the patent term may be extended based on certain delays caused by the applicant(s) or the U.S. Patent and Trademark Office (“USPTO”).
Even if we obtain effective patent rights for our approved product or product candidates, we may not have sufficient patent terms or regulatory
exclusivity to protect our products, and our business and results of operations would be adversely affected.

Patent policy and rule changes could increase
the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents.

Changes in either the patent laws
or interpretation of the patent laws in the U.S. and other countries may diminish the value of our patents or narrow the scope of our
patent protection. The laws of foreign countries may not protect our rights to the same extent as the laws of the U.S. Publications of
discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the U.S. and other jurisdictions
are typically not published until 18 months after filing, or in some cases not at all. We therefore cannot be certain that we or our licensor
were the first to make the invention claimed in our owned and licensed patents or pending applications, or that we or our licensor were
the first to file for patent protection of such inventions. Assuming the other requirements for patentability are met, in the U.S. prior
to March 15, 2013, the first to invent the claimed invention is entitled to the patent, while outside the U.S., the first to file a patent
application is entitled to the patent. After March 15